RUBICON RESEARCH (RUBICON) Share Price Falls 2.22% Today: What the Market Data Shows
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
RUBICON Share Price moved lower today, with RUBICON RESEARCH closing at Rs 1,639.90 after a 2.22% decline. The stock opened at Rs 1,665.10, touched an intraday high of Rs 1,685.00 and a low of Rs 1,639.90, while its market capitalisation stood at Rs 27,762.18 crore. The move is relevant because today’s decline came without a company-specific catalyst in the supplied data, so the session has to be read through price action, valuation and sector context. In this RUBICON Share Price Today update, the data shows a same-day fall from the previous close of Rs 1,677.15, with turnover of Rs 1.2 crore. Univest is tracking the stock as part of its live market coverage so readers can place the move in context.
The latest RUBICON Stock News and RUBICON Share News focus on the arithmetic of the day rather than a disclosed event trigger. That makes the session useful for investors watching RUBICON Stock Falling Today, because it shows how the share price behaved around the opening level, intraday range and closing price. The question for this note is not only why the share price fell, but what the supplied financial and sector numbers say about the company after the decline.
RUBICON RESEARCH (RUBICON) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,639.9 |
| Previous Close | Rs 1,677.15 |
| Today's Move | -Rs 37.25 (-2.22%) |
| Open | Rs 1,665.1 |
| High | Rs 1,685 |
| Low | Rs 1,639.9 |
| Turnover | Rs 1.2 crore |
| Market Capitalisation | Rs 27,762.18 crore |
| Market Cap Category | Large Cap |
RUBICON Share Price Today reflects a session in which the stock opened below the previous close and remained under pressure through the day’s final print. The previous close was Rs 1,677.15, the open was Rs 1,665.10, the day high was Rs 1,685.00 and the day low was Rs 1,639.90, which is also the closing price. The absolute decline was Rs 37.25, matching the 2.22% fall. That places today’s move firmly in the category of a noticeable share price decline, even though the data does not establish a company-specific catalyst.
For readers searching RUBICON Share Price Live or RUBICON Share Price Update, the important point is that the stock finished at the session low, below both the opening price and the previous close. Turnover was Rs 1.2 crore. The company is classified as a Large Cap in the supplied data, and its market cap is Rs 27,762.18 crore. In practical terms, RUBICON Stock News today is about a lower close, a tight intraday range and a fall that must be read with the company’s valuation and sector backdrop. That naturally leads to a deeper look at RUBICON Fundamental Analysis and the stock’s published ratios.
RUBICON RESEARCH (RUBICON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 27,762.18 crore |
| P/E Ratio | 96.32x |
| P/B Ratio | 20.68x |
| ROE | 27.84% |
| ROCE | 29.22% |
| EPS | Rs 17.41 |
| Book Value Per Share | Rs 81.09 |
| Dividend Yield | 0.09% |
RUBICON Fundamental Analysis shows a company with a market capitalisation of Rs 27,762.18 crore, a P/E ratio of 96.32, a P/B ratio of 20.68, ROE of 27.84%, ROCE of 29.22%, EPS of 17.41, book value of Rs 81.09 and dividend yield of 0.09%. Those figures give the RUBICON Share Price context after today’s decline. EPS of Rs 17.41 indicates the earnings attributable to each share, while book value of Rs 81.09 shows the accounting net worth behind each share. Dividend yield of 0.09% is a low historical payout metric relative to the current share price and should be viewed as a data point, not a forecast.
On profitability metrics, ROE of 27.84% and ROCE of 29.22% are both strong on an absolute basis. However, the valuation is also demanding: the P/E ratio of 96.32 and P/B ratio of 20.68 sit well above the broader industry medians shown later in this article. That means RUBICON Share Price is being evaluated against a high earnings multiple and a premium book multiple. Univest’s reading here is simple: the stock’s fall today does not change the fact that the market is still valuing it at elevated ratios compared with many peers in the same industry.
For investors following RUBICON Stock Analysis, the key fundamental question is whether the company can continue to support such a valuation with earnings quality and return ratios. The supplied data confirms the price event and the financial ratios, but not a fresh company catalyst. That makes the current RUBICON Share Price News more about comparison than explanation.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 96.32x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 49.63x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 20.68x |
| Benchmark Median P/B | 2.85x |
| Benchmark Average P/B | 4.33x |
| Company ROE | 27.84% |
| Benchmark Median ROE | 11.48% |
| Benchmark Average ROE | 10.04% |
| Company ROCE | 29.22% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.82% |
| Company Market Capitalisation | Rs 27,762.18 crore |
| Benchmark Median Market Cap | Rs 732.57 crore |
| Benchmark Average Market Cap | Rs 14,043.26 crore |
Sector and Industry Context is important here because RUBICON operates in Healthcare within Pharmaceuticals & Drugs, and the benchmark set supplied for the same industry covers 204 companies. In that benchmark, the company P/E is 96.32 versus an industry median of 32.87 and an industry average of 49.63. The company P/B is 20.68 versus a median of 2.85 and an average of 4.33. ROE at 27.84% is above the industry median of 11.48% and average of 10.04%, while ROCE at 29.22% is above the median of 13.17% and average of 12.82%.
The market capitalisation benchmark context also matters. Across the same industry, the median market cap is Rs 732.57 crore and the average is Rs 14,043.26 crore, while RUBICON’s market cap is Rs 27,762.18 crore. That places the company above both the industry median and average in size terms. In this sector analysis, the share price fall sits alongside a premium valuation, strong returns on capital and a large-cap profile within Healthcare. Univest notes that the stock’s RUBICON Share Price Today movement should therefore be read against a benchmark set where its multiples are higher than the industry’s central tendency.
Sector performance is not quantified in the supplied data, so the most reliable conclusion is that the company is trading with premium valuation metrics relative to its industry group. That is the clearest sector-level context available for RUBICON Stock News and RUBICON Share Price Fall coverage today.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,44,716.74 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,55,115.31 | 87.22 | 14.44 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,613.38 | 86.94 | 21.13 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,899.96 | 26.57 | 4.45 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,875.68 | 33.49 | 3.21 | 11.83 | 16 |
Peer comparison shows that RUBICON stands out more on valuation than on size. Among the supplied healthcare peers, its P/E of 96.32 is above Sun Pharmaceutical Industries at 36.77, Zydus Lifesciences at 26.57, Cipla at 33.49 and Dr. Reddy’s Laboratories at 31.16, while it is close to but below Divi’s Laboratories at 87.22 and Torrent Pharmaceuticals at 86.94. The company’s P/B of 20.68 is also materially above Sun Pharma, Zydus, Cipla and Dr. Reddy’s.
On returns, RUBICON’s ROE of 27.84% and ROCE of 29.22% compare favourably with many of the listed peers, including Sun Pharma, Divi’s, Zydus and Cipla on at least one return metric. On market capitalisation, RUBICON’s Rs 27,762.18 crore is below Sun Pharma and Divi’s, but above Zydus, Cipla, Dr. Reddy’s, Laurus Labs, Mankind Pharma and Aurobindo Pharma in the broader peer set supplied. Univest’s peer view is that the stock’s RUBICON Share Price today is paired with a valuation profile that remains richer than several well-known healthcare names.
Why Investors Are Watching RUBICON
- The RUBICON Share Price fell 2.22% today, losing Rs 37.25 from the previous close.
- The stock closed at Rs 1,639.90 after opening at Rs 1,665.10 and touching Rs 1,685.00 intraday.
- Market capitalisation stood at Rs 27,762.18 crore, with the company classified as a Large Cap in the supplied data.
- P/E is 96.32 and P/B is 20.68, both above the industry median and average supplied for Pharmaceuticals & Drugs.
- ROE of 27.84% and ROCE of 29.22% are above the industry median and average in the supplied sector benchmark.
About RUBICON
About RUBICON: RUBICON RESEARCH is classified in Healthcare and Pharmaceuticals & Drugs. The supplied data also places it within a benchmark set covering 204 companies in the same industry. For RUBICON Share Price readers, that means today’s move should be seen against a healthcare business profile and a broader pharmaceutical peer universe. Univest uses this company context to connect the share price fall with the stock’s published valuation and return metrics, rather than with any unverified narrative about the day’s move.
Track RUBICON Share Price on Univest
Use RUBICON RESEARCH (RUBICON) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Track RUBICON Share Price on Univest for live share price updates, company news, financial ratios, shareholding pattern, 52-week levels and market insights. Univest brings the stock’s price action, fundamental ratios and sector comparison into one place so readers can follow RUBICON Stock News and RUBICON Share Price Today in context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did RUBICON Share Price fall today?
Ans. RUBICON Share Price fell 2.22% to Rs 1,639.90. The supplied data confirms the price event, but it does not establish a company-specific catalyst for the decline. The previous close was Rs 1,677.15.
What was RUBICON Share Price Today’s closing level?
Ans. RUBICON Share Price Today closed at Rs 1,639.90, below the previous close of Rs 1,677.15. The session also printed a day high of Rs 1,685.00 and a day low of Rs 1,639.90.
What is RUBICON’s market capitalisation?
Ans. RUBICON’s market capitalisation is Rs 27,762.18 crore. The company is also classified as a Large Cap in the supplied data, which gives the share price move a size context. The company operates in the Healthcare sector.
How is RUBICON valued versus the industry?
Ans. RUBICON’s P/E of 96.32 and P/B of 20.68 are above the Pharmaceuticals & Drugs industry median and average in the supplied benchmark, while ROE and ROCE are also higher than the benchmark central tendency.
What do RUBICON’s ROE and ROCE indicate?
Ans. RUBICON’s ROE is 27.84% and ROCE is 29.22%. These figures show the company is generating strong returns on equity and capital employed compared with the supplied industry median and average.
How does RUBICON compare with healthcare peers?
Ans. RUBICON’s P/E of 96.32 is higher than Sun Pharma, Zydus, Cipla and Dr. Reddy’s in the supplied peer set. Its ROE and ROCE are also competitive against several listed healthcare names.
